BRCA1 and prostate carcinoma: In the same prostate cancer cell line model, a new HDAC inhibitor, H6CAHA, suppressed the expression of BRCA1 mRNA, and when used in combination with γ-radiation, prevented the growth of tumor xenografts [33].